Table 2.
Treatment thresholds for hypertensive disorders of pregnancy
| Treatment thresholds by guideline | ||||
|---|---|---|---|---|
| ISSHP [75] 2018 |
ACOG [82, 83] 2022 |
ESC [76] 2018 |
NICE [74] 2019 |
|
| Gestational hypertension | SBP ≥ 140 mm Hg or DBP ≥ 90 mmHg | None | SBP ≥ 140 mm Hg or DBP ≥ 90 mmHg | SBP ≥ 150 mm Hg or DBP ≥ 100 mmHg |
| Chronic HTN without organ damage | SBP ≥ 140 mm Hg or DBP ≥ 90 mm Hg | SBP ≥ 140 mm Hg or DBP ≥ 90 mm Hg | SBP ≥ 150 mm Hg or DBP ≥ 95 mmHg | |
| Preeclampsia | SBP ≥ 160 mm Hg or DBP ≥ 90 mm Hg | SBP ≥ 140 mm Hg or DBP ≥ 90 mmHg | SBP ≥ 140 mm Hg or DBP ≥ 90 mmHg | |
| Chronic hypertension with preeclampsia | ||||
| Treatment goal | SBP 110–140 and DBP 80–85 mmHg | None specified | None specified |
SBP < 150 and DBP < 80–100 |
Legend: ISSHP, International Society for the Study of Hypertension in Pregnancy; ACOG, American College of Obstetricians and Gynecologists; ESC, European Society of Cardiology; NICE, National Institute for Health and Care Excellence; SBP, systolic blood pressure; DBP, diastolic blood pressure
(With permission from Incessant Nature Science Publishers Pvt. Ltd.) [80]